Jacquelien ten Dam

Director/Board Member presso MAUNA KEA TECHNOLOGIES

Health Technology

Consumer Services

Profilo

Jacquelien ten Dam is an Independent Director at Mauna Kea Technologies SA and the Chief Financial Officer at Mimetas BV.
She graduated from the University of Leiden.

Posizioni attive di Jacquelien ten Dam

Società	Posizione	Inizio
MAUNA KEA TECHNOLOGIES	Director/Board Member	01/01/2021
Mimetas BV Mimetas BV BiotechnologyHealth Technology Mimetas BV develops organ-on-a-chip technology for testing of new medicines in high-throughput on miniaturized organ and disease models. It develops microfluidics-based culture plates that enable culturing and screening of a range of 3D organ and tissue models. The firm offers OrganoPlates microfluidics-based culture plates that serve as early stage screening models predicting toxic side effects and drug efficacy. The company was founded by Paul Vulto and Jos Joore in 2013 and is headquartered in Leiden, the Netherlands.	Director of Finance/CFO	-

Tutte le posizioni attive di Jacquelien ten Dam

Formazione di Jacquelien ten Dam

University of Leiden

Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Jacquelien ten Dam

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
MAUNA KEA TECHNOLOGIES	Health Technology

Aziende private	1
Mimetas BV Mimetas BV BiotechnologyHealth Technology Mimetas BV develops organ-on-a-chip technology for testing of new medicines in high-throughput on miniaturized organ and disease models. It develops microfluidics-based culture plates that enable culturing and screening of a range of 3D organ and tissue models. The firm offers OrganoPlates microfluidics-based culture plates that serve as early stage screening models predicting toxic side effects and drug efficacy. The company was founded by Paul Vulto and Jos Joore in 2013 and is headquartered in Leiden, the Netherlands.	Health Technology